Gudrun Göhring

15.1k total citations
183 papers, 5.1k citations indexed

About

Gudrun Göhring is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Gudrun Göhring has authored 183 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 96 papers in Hematology and 38 papers in Genetics. Recurrent topics in Gudrun Göhring's work include Acute Myeloid Leukemia Research (86 papers), Pluripotent Stem Cells Research (32 papers) and CRISPR and Genetic Engineering (29 papers). Gudrun Göhring is often cited by papers focused on Acute Myeloid Leukemia Research (86 papers), Pluripotent Stem Cells Research (32 papers) and CRISPR and Genetic Engineering (29 papers). Gudrun Göhring collaborates with scholars based in Germany, United States and United Kingdom. Gudrun Göhring's co-authors include Brigitte Schlegelberger, Arnold Ganser, Michael Heuser, Jürgen Krauter, Felicitas Thol, Frédérik Damm, Katharina Wagner, Ulrich Martin, Oliver G. Ottmann and Hans Kreipe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Gudrun Göhring

176 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gudrun Göhring Germany 37 3.1k 2.7k 1.4k 770 559 183 5.1k
Thoas Fioretos Sweden 39 2.5k 0.8× 2.5k 1.0× 1.1k 0.8× 983 1.3× 1.2k 2.1× 153 5.6k
Masashi Sanada Japan 33 1.3k 0.4× 2.2k 0.8× 630 0.5× 920 1.2× 369 0.7× 118 4.1k
Rashmi Kanagal‐Shamanna United States 34 1.9k 0.6× 1.2k 0.4× 1.3k 1.0× 825 1.1× 477 0.9× 223 4.0k
Roland P. Kuiper Netherlands 35 1.5k 0.5× 2.6k 1.0× 473 0.3× 1.1k 1.5× 1.2k 2.2× 123 5.4k
Olga I. Gan Canada 22 1.6k 0.5× 2.0k 0.8× 745 0.5× 523 0.7× 169 0.3× 51 4.1k
Hana Raslová France 29 3.1k 1.0× 2.4k 0.9× 3.2k 2.3× 231 0.3× 107 0.2× 75 5.2k
Louise E. Purton Australia 31 1.7k 0.6× 2.2k 0.8× 624 0.5× 550 0.7× 143 0.3× 85 4.0k
Héctor Mayani Mexico 32 2.1k 0.7× 1.1k 0.4× 1.5k 1.1× 231 0.3× 198 0.4× 155 3.7k
Virginia C. Broudy United States 17 1.7k 0.5× 2.0k 0.7× 727 0.5× 221 0.3× 224 0.4× 32 4.8k
Claudia S. Huettner United States 24 1.5k 0.5× 1.5k 0.6× 689 0.5× 330 0.4× 188 0.3× 44 3.3k

Countries citing papers authored by Gudrun Göhring

Since Specialization
Citations

This map shows the geographic impact of Gudrun Göhring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Göhring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Göhring more than expected).

Fields of papers citing papers by Gudrun Göhring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gudrun Göhring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Göhring. The network helps show where Gudrun Göhring may publish in the future.

Co-authorship network of co-authors of Gudrun Göhring

This figure shows the co-authorship network connecting the top 25 collaborators of Gudrun Göhring. A scholar is included among the top collaborators of Gudrun Göhring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gudrun Göhring. Gudrun Göhring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiss, Julia Miriam, Irene González-Menéndez, Geoffroy Andrieux, et al.. (2025). PUMA-induced apoptosis drives bone marrow failure and genomic instability in telomerase-deficient mice. Cell Death and Differentiation. 33(1). 38–50.
2.
Eiben, B., et al.. (2024). Nicht-invasiver Pränataltest (NIPT): Aktuelle gesundheitspolitische Initiativen und inhaltliche Missverständnisse. Medizinische Genetik. 36(3). 189–192. 1 indexed citations
3.
Manstein, Felix, Annika Franke, Jana Teske, et al.. (2024). Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation. Stem Cell Research & Therapy. 15(1). 89–89. 7 indexed citations
5.
Behrens, Yvonne Lisa, Andrea Schienke, Jana Lentes, et al.. (2021). BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone. Cancer Genetics. 254-255. 70–74. 3 indexed citations
6.
Thomay, Kathrin, Jana Lentes, Yvonne Lisa Behrens, et al.. (2021). Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing. Genes Chromosomes and Cancer. 61(1). 22–26. 4 indexed citations
7.
Morlot, Susanne, Gunnar Schmidt, Bernd Auber, et al.. (2020). De novo missense variants in the RAP1B gene identified in two patients with syndromic thrombocytopenia. Clinical Genetics. 98(4). 374–378. 5 indexed citations
8.
Kurtz, Stefanie, Andrea Lucas‐Hahn, Brigitte Schlegelberger, et al.. (2020). Knockout of the HMG domain of the porcine SRY gene causes sex reversal in gene-edited pigs. Proceedings of the National Academy of Sciences. 118(2). 30 indexed citations
9.
Nowak‐Imialek, Monika, Stephanie Wunderlich, Doris Herrmann, et al.. (2020). In Vitro and In Vivo Interspecies Chimera Assay Using Early Pig Embryos. Cellular Reprogramming. 22(3). 118–133. 4 indexed citations
10.
Kattih, Badder, Piroska Klement, Abel Martin Garrido, et al.. (2020). IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis. Leukemia. 35(5). 1301–1316. 37 indexed citations
11.
Fuchs, Nina V., Maximilian Schieck, Christiane Tondera, et al.. (2019). Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Research. 41. 101592–101592. 1 indexed citations
12.
Fuchs, Nina V., Maximilian Schieck, Christiane Tondera, et al.. (2019). Induced pluripotent stem cell line (PEIi003-A) derived from an apparently healthy male individual. Stem Cell Research. 42. 101679–101679.
13.
Drick, Nora, Anais Sahabian, Sylvia Merkert, et al.. (2019). Generation of a NKX2.1 – p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4). Stem Cell Research. 42. 101659–101659. 4 indexed citations
14.
Happle, Christine, Nico Lachmann, Mania Ackermann, et al.. (2018). Pulmonary Transplantation of Human Induced Pluripotent Stem Cell–derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis. American Journal of Respiratory and Critical Care Medicine. 198(3). 350–360. 53 indexed citations
16.
Middeke, Jan Moritz, Dietrich W. Beelen, Michael Stadler, et al.. (2012). Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−. Blood. 120(12). 2521–2528. 42 indexed citations
17.
Hemmer, Kathrin, Inga Bernemann, Gudrun Göhring, et al.. (2012). Induced Pluripotent Stem Cells Generated from Adult Bone Marrow–Derived Cells of the Nonhuman Primate (Callithrix jacchus) Using a Novel Quad-Cistronic and Excisable Lentiviral Vector. Cellular Reprogramming. 14(6). 485–496. 31 indexed citations
19.
Jädersten, Martin, Leonie Saft, Alexander Smith, et al.. (2011). TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression. Journal of Clinical Oncology. 29(15). 1971–1979. 332 indexed citations
20.
Hussein, Kais, Katharina Theophile, Guntram Büsche, et al.. (2009). Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leukemia Research. 34(3). 328–334. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026